An Open-Label, Randomized Crossover Study to Evaluate the Acceptability and Preference for Contraceptive Options in Healthy HIV-Uninfected Female Adolescents, 16-17 Years of Age, as Proxy for HIV Prevention Methods

Trial Profile

An Open-Label, Randomized Crossover Study to Evaluate the Acceptability and Preference for Contraceptive Options in Healthy HIV-Uninfected Female Adolescents, 16-17 Years of Age, as Proxy for HIV Prevention Methods

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 26 Jul 2017

At a glance

  • Drugs Ethinylestradiol/etonogestrel (Primary) ; Ethinylestradiol/levonorgestrel
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms UChoose
  • Most Recent Events

    • 21 Jul 2017 Planned End Date changed from 1 Feb 2016 to 1 Feb 2018.
    • 21 Jul 2017 Planned primary completion date changed from 1 Feb 2016 to 1 Dec 2017.
    • 21 Jul 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top